Company profile
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G
Nuvectis Pharma, Inc.
6 Feb 24
4
Keros Therapeutics, Inc.
30 Nov 22
3/A
Keros Therapeutics, Inc.
30 Nov 22
4
Eloxx Pharmaceuticals, Inc.
17 May 21
4
Keros Therapeutics, Inc.
19 Nov 20
4
Eloxx Pharmaceuticals, Inc.
22 May 20
SC 13D
Keros Therapeutics, Inc.
23 Apr 20
4
Keros Therapeutics, Inc.
13 Apr 20
3
Keros Therapeutics, Inc.
7 Apr 20
4
Tomer Kariv
13 Nov 19